Skip to main content

Table 5 Overall and progression free survival.

From: Salvage therapy of pretreated advanced breast cancer with bevacizumab and paclitaxel every two weeks: a retrospective case review study

  Total
OS  
   Median > 20 months
   6 month 89.5%
   12 month 83.4%
PFS  
Median
(months, 95% CI)
12.1
(8.4-15.8)
   6 month 80.3%
   12 month 51.8%